Patent details

EP2595653 Title: INFLUENZA VACCINE

Basic Information

Publication number:
EP2595653
PCT Application Number:
SE2011050968
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP118099555
PCT Publication Number:
WO2012011868
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INFLUENZA VACCINE
French Title of Invention:
VACCIN ANTIGRIPPAL
German Title of Invention:
INFLUENZA-IMPFSTOFF
SPC Number:

Dates

Filing date:
25/07/2011
Grant date:
28/06/2017
EP Publication Date:
29/05/2013
PCT Publication Date:
26/01/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/06/2017
EP B1 Publication Date:
28/06/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
25/07/2017
Expiration date:
25/07/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/06/2017
 
 

Name:
Erasmus University Rotterdam Medical Center
Address:
Dr. Molewaterplein 50-60, 3015 GE Rotterdam, Netherlands (NL)

Name:
Novavax AB
Address:
Kungsgatan 109, 753 18 Uppsala, Sweden (SE)

Inventor

1

Name:
OSTERHAUS, A.D.M.E.
Address:
Netherlands (NL)

2

Name:
MOREIN, Bror
Address:
Sweden (SE)

3

Name:
BENGTSSON LÖVGREN, Karin
Address:
Sweden (SE)

Priority

Priority Number:
366983 P
Priority Date:
23/07/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/145; A61K 39/39; A61P 31/16;

Publication

European Patent Bulletin

1

Issue number:
201726
Publication date:
28/06/2017
Description:
Grant (B1)

2

Issue number:
201729
Publication date:
19/07/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/11/2017 Outgoing Correspondence 1